nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCG2—Dactinomycin—muscle cancer	0.111	0.125	CbGbCtD
Nelfinavir—ABCG2—Vincristine—muscle cancer	0.0683	0.0772	CbGbCtD
Nelfinavir—ABCG2—Etoposide—muscle cancer	0.0626	0.0708	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—muscle cancer	0.0552	0.0624	CbGbCtD
Nelfinavir—CYP1A2—Dacarbazine—muscle cancer	0.0527	0.0596	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—muscle cancer	0.052	0.0588	CbGbCtD
Nelfinavir—CYP3A7—Vincristine—muscle cancer	0.0504	0.057	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0504	0.057	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—muscle cancer	0.0427	0.0483	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—muscle cancer	0.0413	0.0467	CbGbCtD
Nelfinavir—ABCB1—Dactinomycin—muscle cancer	0.04	0.0452	CbGbCtD
Nelfinavir—CYP3A5—Vincristine—muscle cancer	0.0378	0.0428	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—muscle cancer	0.0347	0.0392	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—muscle cancer	0.03	0.0339	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—muscle cancer	0.0258	0.0292	CbGbCtD
Nelfinavir—ABCB1—Vincristine—muscle cancer	0.0246	0.0278	CbGbCtD
Nelfinavir—ABCB1—Etoposide—muscle cancer	0.0226	0.0255	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—muscle cancer	0.0154	0.0174	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—muscle cancer	0.0149	0.0169	CbGbCtD
Nelfinavir—CYP3A4—Vincristine—muscle cancer	0.0148	0.0167	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—muscle cancer	0.0145	0.0164	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—muscle cancer	0.0135	0.0153	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—muscle cancer	0.00922	0.0104	CbGbCtD
Nelfinavir—Sweating—Vincristine—muscle cancer	0.000671	0.00581	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.000668	0.00578	CcSEcCtD
Nelfinavir—Erythema multiforme—Dactinomycin—muscle cancer	0.000665	0.00576	CcSEcCtD
Nelfinavir—Cramp muscle—Etoposide—muscle cancer	0.000663	0.00574	CcSEcCtD
Nelfinavir—Hyperuricaemia—Methotrexate—muscle cancer	0.000655	0.00567	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Etoposide—muscle cancer	0.000649	0.00562	CcSEcCtD
Nelfinavir—Hepatic enzyme increased—Methotrexate—muscle cancer	0.000642	0.00556	CcSEcCtD
Nelfinavir—Inflammation—Methotrexate—muscle cancer	0.000626	0.00542	CcSEcCtD
Nelfinavir—Bronchospasm—Etoposide—muscle cancer	0.000626	0.00542	CcSEcCtD
Nelfinavir—Blood uric acid increased—Methotrexate—muscle cancer	0.000619	0.00536	CcSEcCtD
Nelfinavir—Connective tissue disorder—Vincristine—muscle cancer	0.000618	0.00535	CcSEcCtD
Nelfinavir—Erythema—Dactinomycin—muscle cancer	0.000613	0.0053	CcSEcCtD
Nelfinavir—Neutropenia—Etoposide—muscle cancer	0.000595	0.00515	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.000578	0.00501	CcSEcCtD
Nelfinavir—Pneumonia—Etoposide—muscle cancer	0.000571	0.00494	CcSEcCtD
Nelfinavir—Angiopathy—Vincristine—muscle cancer	0.00057	0.00494	CcSEcCtD
Nelfinavir—Ill-defined disorder—Dactinomycin—muscle cancer	0.000568	0.00492	CcSEcCtD
Nelfinavir—Hyperuricaemia—Doxorubicin—muscle cancer	0.000567	0.00491	CcSEcCtD
Nelfinavir—Anaemia—Dactinomycin—muscle cancer	0.000566	0.0049	CcSEcCtD
Nelfinavir—Stomatitis—Etoposide—muscle cancer	0.000553	0.00479	CcSEcCtD
Nelfinavir—Jaundice—Etoposide—muscle cancer	0.000553	0.00479	CcSEcCtD
Nelfinavir—Malaise—Dactinomycin—muscle cancer	0.000552	0.00478	CcSEcCtD
Nelfinavir—Mouth ulceration—Methotrexate—muscle cancer	0.000549	0.00476	CcSEcCtD
Nelfinavir—Leukopenia—Dactinomycin—muscle cancer	0.000548	0.00475	CcSEcCtD
Nelfinavir—Inflammation—Doxorubicin—muscle cancer	0.000542	0.0047	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Etoposide—muscle cancer	0.000537	0.00465	CcSEcCtD
Nelfinavir—Blood uric acid increased—Doxorubicin—muscle cancer	0.000536	0.00464	CcSEcCtD
Nelfinavir—Back pain—Vincristine—muscle cancer	0.000529	0.00458	CcSEcCtD
Nelfinavir—Myalgia—Dactinomycin—muscle cancer	0.000522	0.00452	CcSEcCtD
Nelfinavir—Discomfort—Dactinomycin—muscle cancer	0.000515	0.00446	CcSEcCtD
Nelfinavir—Diabetes mellitus—Methotrexate—muscle cancer	0.000507	0.00439	CcSEcCtD
Nelfinavir—Anaemia—Vincristine—muscle cancer	0.000506	0.00438	CcSEcCtD
Nelfinavir—Agitation—Vincristine—muscle cancer	0.000503	0.00435	CcSEcCtD
Nelfinavir—Oedema—Dactinomycin—muscle cancer	0.0005	0.00433	CcSEcCtD
Nelfinavir—Leukopenia—Vincristine—muscle cancer	0.00049	0.00424	CcSEcCtD
Nelfinavir—Thrombocytopenia—Dactinomycin—muscle cancer	0.000489	0.00424	CcSEcCtD
Nelfinavir—Erythema multiforme—Etoposide—muscle cancer	0.000482	0.00417	CcSEcCtD
Nelfinavir—Rash maculo-papular—Doxorubicin—muscle cancer	0.000478	0.00414	CcSEcCtD
Nelfinavir—Anorexia—Dactinomycin—muscle cancer	0.000477	0.00413	CcSEcCtD
Nelfinavir—Eye disorder—Etoposide—muscle cancer	0.000476	0.00412	CcSEcCtD
Nelfinavir—Mouth ulceration—Doxorubicin—muscle cancer	0.000476	0.00412	CcSEcCtD
Nelfinavir—Convulsion—Vincristine—muscle cancer	0.000474	0.00411	CcSEcCtD
Nelfinavir—Myalgia—Vincristine—muscle cancer	0.000466	0.00403	CcSEcCtD
Nelfinavir—Angiopathy—Etoposide—muscle cancer	0.000462	0.004	CcSEcCtD
Nelfinavir—Immune system disorder—Etoposide—muscle cancer	0.00046	0.00398	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000455	0.00394	CcSEcCtD
Nelfinavir—Oedema—Vincristine—muscle cancer	0.000447	0.00387	CcSEcCtD
Nelfinavir—Diabetes mellitus—Doxorubicin—muscle cancer	0.000439	0.0038	CcSEcCtD
Nelfinavir—Thrombocytopenia—Vincristine—muscle cancer	0.000437	0.00379	CcSEcCtD
Nelfinavir—Decreased appetite—Dactinomycin—muscle cancer	0.000435	0.00376	CcSEcCtD
Nelfinavir—Hyperhidrosis—Vincristine—muscle cancer	0.000432	0.00374	CcSEcCtD
Nelfinavir—Back pain—Etoposide—muscle cancer	0.000429	0.00371	CcSEcCtD
Nelfinavir—Pain—Dactinomycin—muscle cancer	0.000428	0.0037	CcSEcCtD
Nelfinavir—Muscle spasms—Etoposide—muscle cancer	0.000426	0.00369	CcSEcCtD
Nelfinavir—Anorexia—Vincristine—muscle cancer	0.000426	0.00369	CcSEcCtD
Nelfinavir—Mood swings—Methotrexate—muscle cancer	0.000418	0.00362	CcSEcCtD
Nelfinavir—Feeling abnormal—Dactinomycin—muscle cancer	0.000412	0.00357	CcSEcCtD
Nelfinavir—Ill-defined disorder—Etoposide—muscle cancer	0.000411	0.00356	CcSEcCtD
Nelfinavir—Anaemia—Etoposide—muscle cancer	0.00041	0.00355	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000409	0.00354	CcSEcCtD
Nelfinavir—Liver function test abnormal—Methotrexate—muscle cancer	0.000407	0.00353	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000407	0.00352	CcSEcCtD
Nelfinavir—Insomnia—Vincristine—muscle cancer	0.000404	0.0035	CcSEcCtD
Nelfinavir—Paraesthesia—Vincristine—muscle cancer	0.000401	0.00347	CcSEcCtD
Nelfinavir—Malaise—Etoposide—muscle cancer	0.0004	0.00346	CcSEcCtD
Nelfinavir—Dermatitis bullous—Doxorubicin—muscle cancer	0.0004	0.00346	CcSEcCtD
Nelfinavir—Leukopenia—Etoposide—muscle cancer	0.000397	0.00344	CcSEcCtD
Nelfinavir—Abdominal pain—Dactinomycin—muscle cancer	0.000395	0.00342	CcSEcCtD
Nelfinavir—Body temperature increased—Dactinomycin—muscle cancer	0.000395	0.00342	CcSEcCtD
Nelfinavir—Hypoglycaemia—Doxorubicin—muscle cancer	0.000391	0.00339	CcSEcCtD
Nelfinavir—Decreased appetite—Vincristine—muscle cancer	0.000388	0.00336	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Vincristine—muscle cancer	0.000386	0.00334	CcSEcCtD
Nelfinavir—Convulsion—Etoposide—muscle cancer	0.000384	0.00333	CcSEcCtD
Nelfinavir—Pain—Vincristine—muscle cancer	0.000382	0.00331	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000382	0.00331	CcSEcCtD
Nelfinavir—Affect lability—Doxorubicin—muscle cancer	0.000376	0.00325	CcSEcCtD
Nelfinavir—Migraine—Doxorubicin—muscle cancer	0.000376	0.00325	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000375	0.00325	CcSEcCtD
Nelfinavir—Pancreatitis—Methotrexate—muscle cancer	0.000374	0.00324	CcSEcCtD
Nelfinavir—Discomfort—Etoposide—muscle cancer	0.000373	0.00323	CcSEcCtD
Nelfinavir—Hypersensitivity—Dactinomycin—muscle cancer	0.000368	0.00319	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Vincristine—muscle cancer	0.000365	0.00316	CcSEcCtD
Nelfinavir—Mood swings—Doxorubicin—muscle cancer	0.000362	0.00313	CcSEcCtD
Nelfinavir—Asthenia—Dactinomycin—muscle cancer	0.000359	0.00311	CcSEcCtD
Nelfinavir—Neutropenia—Methotrexate—muscle cancer	0.000356	0.00309	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—muscle cancer	0.000355	0.00307	CcSEcCtD
Nelfinavir—Thrombocytopenia—Etoposide—muscle cancer	0.000354	0.00307	CcSEcCtD
Nelfinavir—Abdominal pain—Vincristine—muscle cancer	0.000353	0.00306	CcSEcCtD
Nelfinavir—Body temperature increased—Vincristine—muscle cancer	0.000353	0.00306	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—muscle cancer	0.000353	0.00305	CcSEcCtD
Nelfinavir—Skin disorder—Etoposide—muscle cancer	0.000351	0.00304	CcSEcCtD
Nelfinavir—Hyperhidrosis—Etoposide—muscle cancer	0.00035	0.00303	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—muscle cancer	0.000349	0.00302	CcSEcCtD
Nelfinavir—Anorexia—Etoposide—muscle cancer	0.000345	0.00299	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000344	0.00298	CcSEcCtD
Nelfinavir—Diarrhoea—Dactinomycin—muscle cancer	0.000342	0.00296	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—muscle cancer	0.000342	0.00296	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—muscle cancer	0.000337	0.00292	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000337	0.00292	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—muscle cancer	0.000332	0.00288	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—muscle cancer	0.000331	0.00287	CcSEcCtD
Nelfinavir—Hypersensitivity—Vincristine—muscle cancer	0.000329	0.00285	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—muscle cancer	0.000326	0.00282	CcSEcCtD
Nelfinavir—Paraesthesia—Etoposide—muscle cancer	0.000325	0.00281	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—muscle cancer	0.000324	0.0028	CcSEcCtD
Nelfinavir—Dyspnoea—Etoposide—muscle cancer	0.000323	0.00279	CcSEcCtD
Nelfinavir—Somnolence—Etoposide—muscle cancer	0.000322	0.00279	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—muscle cancer	0.000321	0.00278	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—muscle cancer	0.000321	0.00278	CcSEcCtD
Nelfinavir—Asthenia—Vincristine—muscle cancer	0.00032	0.00277	CcSEcCtD
Nelfinavir—Vomiting—Dactinomycin—muscle cancer	0.000318	0.00275	CcSEcCtD
Nelfinavir—Rash—Dactinomycin—muscle cancer	0.000315	0.00273	CcSEcCtD
Nelfinavir—Decreased appetite—Etoposide—muscle cancer	0.000315	0.00272	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Etoposide—muscle cancer	0.000312	0.0027	CcSEcCtD
Nelfinavir—Pain—Etoposide—muscle cancer	0.000309	0.00268	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—muscle cancer	0.000309	0.00267	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—muscle cancer	0.000307	0.00265	CcSEcCtD
Nelfinavir—Diarrhoea—Vincristine—muscle cancer	0.000306	0.00265	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—muscle cancer	0.000305	0.00264	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—muscle cancer	0.000305	0.00264	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—muscle cancer	0.000303	0.00262	CcSEcCtD
Nelfinavir—Feeling abnormal—Etoposide—muscle cancer	0.000298	0.00258	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—muscle cancer	0.000298	0.00258	CcSEcCtD
Nelfinavir—Nausea—Dactinomycin—muscle cancer	0.000297	0.00257	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—muscle cancer	0.000296	0.00256	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—muscle cancer	0.000296	0.00256	CcSEcCtD
Nelfinavir—Dizziness—Vincristine—muscle cancer	0.000295	0.00256	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—muscle cancer	0.000288	0.0025	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—muscle cancer	0.000287	0.00249	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—muscle cancer	0.000287	0.00248	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—muscle cancer	0.000287	0.00248	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—muscle cancer	0.000286	0.00248	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—muscle cancer	0.000286	0.00248	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—muscle cancer	0.000285	0.00247	CcSEcCtD
Nelfinavir—Vomiting—Vincristine—muscle cancer	0.000284	0.00246	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—muscle cancer	0.000282	0.00244	CcSEcCtD
Nelfinavir—Rash—Vincristine—muscle cancer	0.000282	0.00244	CcSEcCtD
Nelfinavir—Dermatitis—Vincristine—muscle cancer	0.000281	0.00244	CcSEcCtD
Nelfinavir—Headache—Vincristine—muscle cancer	0.00028	0.00242	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000278	0.00241	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—muscle cancer	0.000278	0.0024	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—muscle cancer	0.000277	0.0024	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—muscle cancer	0.000276	0.00239	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—muscle cancer	0.000276	0.00239	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—muscle cancer	0.000267	0.00231	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—muscle cancer	0.000266	0.0023	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—muscle cancer	0.000266	0.0023	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—muscle cancer	0.000265	0.0023	CcSEcCtD
Nelfinavir—Nausea—Vincristine—muscle cancer	0.000265	0.0023	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—muscle cancer	0.000265	0.00229	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—muscle cancer	0.000264	0.00229	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—muscle cancer	0.000264	0.00229	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—muscle cancer	0.000262	0.00227	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—muscle cancer	0.00026	0.00225	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—muscle cancer	0.00026	0.00225	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—muscle cancer	0.000257	0.00222	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—muscle cancer	0.000256	0.00222	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—muscle cancer	0.00025	0.00216	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—muscle cancer	0.000248	0.00214	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—muscle cancer	0.000247	0.00214	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—muscle cancer	0.000246	0.00213	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—muscle cancer	0.000245	0.00213	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—muscle cancer	0.00024	0.00208	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—muscle cancer	0.000239	0.00207	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—muscle cancer	0.000239	0.00207	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—muscle cancer	0.000239	0.00207	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—muscle cancer	0.000238	0.00206	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—muscle cancer	0.00023	0.00199	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—muscle cancer	0.00023	0.00199	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—muscle cancer	0.00023	0.00199	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—muscle cancer	0.00023	0.00199	CcSEcCtD
Nelfinavir—Rash—Etoposide—muscle cancer	0.000228	0.00198	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—muscle cancer	0.000228	0.00197	CcSEcCtD
Nelfinavir—Headache—Etoposide—muscle cancer	0.000227	0.00196	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—muscle cancer	0.000227	0.00196	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—muscle cancer	0.000226	0.00196	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—muscle cancer	0.000226	0.00196	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000225	0.00194	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—muscle cancer	0.000223	0.00193	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—muscle cancer	0.000222	0.00193	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—muscle cancer	0.000221	0.00191	CcSEcCtD
Nelfinavir—Nausea—Etoposide—muscle cancer	0.000215	0.00186	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—muscle cancer	0.000213	0.00185	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—muscle cancer	0.000213	0.00184	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—muscle cancer	0.000212	0.00184	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—muscle cancer	0.000211	0.00183	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—muscle cancer	0.000211	0.00182	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—muscle cancer	0.00021	0.00181	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—muscle cancer	0.000207	0.0018	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—muscle cancer	0.000207	0.00179	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—muscle cancer	0.000206	0.00178	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—muscle cancer	0.000199	0.00173	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000197	0.00171	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—muscle cancer	0.000196	0.0017	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—muscle cancer	0.000196	0.0017	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—muscle cancer	0.000196	0.0017	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—muscle cancer	0.000195	0.00169	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—muscle cancer	0.000195	0.00169	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000194	0.00168	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—muscle cancer	0.000193	0.00167	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—muscle cancer	0.000193	0.00167	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—muscle cancer	0.000193	0.00167	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—muscle cancer	0.000191	0.00165	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—muscle cancer	0.000188	0.00163	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—muscle cancer	0.000188	0.00162	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000187	0.00162	CcSEcCtD
Nelfinavir—Pain—Methotrexate—muscle cancer	0.000185	0.0016	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—muscle cancer	0.000184	0.00159	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—muscle cancer	0.000182	0.00158	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—muscle cancer	0.000181	0.00157	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—muscle cancer	0.000179	0.00155	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—muscle cancer	0.000179	0.00155	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000177	0.00153	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—muscle cancer	0.000172	0.00149	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—muscle cancer	0.000171	0.00148	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—muscle cancer	0.000171	0.00148	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000171	0.00148	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—muscle cancer	0.00017	0.00147	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—muscle cancer	0.000169	0.00146	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—muscle cancer	0.000167	0.00145	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—muscle cancer	0.000167	0.00144	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—muscle cancer	0.000165	0.00143	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—muscle cancer	0.000163	0.00141	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000162	0.0014	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—muscle cancer	0.00016	0.00139	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—muscle cancer	0.00016	0.00138	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—muscle cancer	0.000155	0.00135	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—muscle cancer	0.000155	0.00134	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000153	0.00133	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—muscle cancer	0.000153	0.00133	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—muscle cancer	0.000149	0.00129	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—muscle cancer	0.000148	0.00128	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—muscle cancer	0.000148	0.00128	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—muscle cancer	0.000148	0.00128	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—muscle cancer	0.000143	0.00124	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—muscle cancer	0.000138	0.0012	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—muscle cancer	0.000138	0.00119	CcSEcCtD
Nelfinavir—Rash—Methotrexate—muscle cancer	0.000137	0.00118	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—muscle cancer	0.000137	0.00118	CcSEcCtD
Nelfinavir—Headache—Methotrexate—muscle cancer	0.000136	0.00118	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—muscle cancer	0.000135	0.00117	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—muscle cancer	0.000133	0.00115	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—muscle cancer	0.000129	0.00111	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—muscle cancer	0.000128	0.00111	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—muscle cancer	0.000124	0.00107	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—muscle cancer	0.000119	0.00103	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—muscle cancer	0.000118	0.00102	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—muscle cancer	0.000118	0.00102	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—muscle cancer	0.000118	0.00102	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—muscle cancer	0.000111	0.000965	CcSEcCtD
